Skip to content

Determination of the efficacy of royal jelly dressing on the healing of diabetic foot ulcer

Determination of the efficacy of royal jelly dressing on the healing of diabetic foot ulcer

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT201009263278N2
Enrollment
70
Registered
2010-10-06
Start date
2010-01-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Foot. Diabetes mellitus

Interventions

Intervention 1: Treatment of diabetic foot ulcers with Royal Jelly, follow up twice a week for 6 months with precise measurements (With digital measurement device), evaluation of diameter, depth, perc
Treatment - Drugs
Treatment of diabetic foot ulcers with Royal Jelly, follow up twice a week for 6 months with precise measurements (With digital measurement device), evaluation of diameter, depth, percentage of healin
Treatment of diabetic foot ulcers with placebo gel, follow up twice a week for 6 months with precise measurements (With digital measurement device), evaluation of diameter, depth, percentage of healin

Sponsors

Isfahan University Of Medical Sciences and Health Services
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Exclusion criteria: 1) Drug side effects (hypersensitivity to RJ) 2) Inappropriate follow up by the patient (i.e., if the patient does not refer for 3 continuous sessions or if the patient attends less than 50% of the total sessions.) 3) Patient’s desire for leaving in each stage of the study 4) Presence of no change in the ulcer (i.e., infection, diameter, and depth reduction) by the end of 12th week of the study (These patients will be mentioned as non responder cases in the final analysis.) Conditions of not including: 1) Patient preference for receiving the treatment out of the study 2) Foot gangrene such that a surgical treatment is required 3) Severe sepsis (at the presentation until recovery) 4) Impending gangrene until angioplasty will be done 5) Use of drugs which may interact with wound healing (e.g., Glucocorticoids,etc)

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Diameter reduction rate. Timepoint: twice a week for 6 months. Method of measurement: evaluation of diameter with precise measurement with Digital measurement device.;Depth reduction rate. Timepoint: twice a week for 6 months. Method of measurement: evaluation of depth of wound with precise measurement with sterile probe with Digital measurement device.;Percentage of complete healing. Timepoint: twice a week for 6 months. Method of measurement: evaluation of percentage of complete healing with precise measurement with Digital measurement device.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Mansour Siavash

Isfahan Medical University

siavash@med.mui.ac.ir+98 31 1459 3749

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026